LPL Financial’s Filana Therapeutics FLNA Stock Holding History
Bought
Maintained
Sold
Other funds holding FLNA
VCM
GC
LPL Financial's FLNA Position: Q1 2026 in Review
LPL Financial reduced its Filana Therapeutics (FLNA) stake by 5.6% in Q1 2026, selling an estimated $5.01K and leaving 40,993 shares worth $69.3K. The position accounts for ﹤0.01% of the portfolio, ranked #5736.
LPL Financial first reported a position in FLNA in Q3 2021 and has held it in 19 quarters since. The position peaked at $2.34M in Q3 2024. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.
- LPL Financial held 40,993 shares of Filana Therapeutics worth $69.3K as of Q1 2026.
- LPL Financial sold 2,434 Filana Therapeutics shares in Q1 2026, an estimated $5.01K.
- Filana Therapeutics made up ﹤0.01% of LPL Financial's portfolio in Q1 2026, its #5736 holding.
- LPL Financial first reported a position in Filana Therapeutics in Q3 2021 and has held it in 19 quarters since.
- LPL Financial's Filana Therapeutics position peaked at $2.34M in Q3 2024.
- 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.
Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.